Subchapter C - DRUGS: GENERAL
- Part 200 - GENERAL (§§ 200.5 — 200.200)
- Part 201 - LABELING (§§ 201.1 — 201)
- Part 202 - PRESCRIPTION DRUG ADVERTISING (§ 202.1)
- Part 203 - PRESCRIPTION DRUG MARKETING (§§ 203.1 — 203.70)
- Part 205 - GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS (§§ 205.1 — 205.50)
- Part 206 - IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE (§§ 206.1 — 206.10)
- Part 207 - REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE (§§ 207.1 — 207.81)
- Part 208 - MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS (§§ 208.1 — 208.26)
- Part 209 - REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT (§§ 209.1 — 209.11)
- Part 210 - CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL (§§ 210.1 — 210.3)
- Part 211 - CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS (§§ 211.1 — 211.208)
- Part 212 - CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS (§§ 212.1 — 212.110)
- Part 216 - HUMAN DRUG COMPOUNDING (§§ 216.23 — 216.24)
- Part 225 - CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS (§§ 225.1 — 225.202)
- Part 226 - CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES (§§ 226.1 — 226.115)
- Part 250 - SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS (§§ 250.11 — 250.250)
- Part 251 - SECTION 804 IMPORTATION PROGRAM (§§ 251.1 — 251.21)
- Part 290 - CONTROLLED DRUGS (§§ 290.1 — 290.10)
- Part 299 - DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES (§§ 299.3 — 299.5)